Insider Brief
- IonQ announced the pricing of a $2.0 billion equity offering consisting of common stock, pre-funded warrants, and seven-year warrants sold to an entity managed by Heights Capital Management, Inc.
- The offering includes 16.5 million common shares and 5 million pre-funded warrants priced at $93 each — a 20 percent premium to IonQ’s October 9 closing price — and 43 million seven-year warrants exercisable at $155 per share, a 100 percent premium.
- IonQ stated the $2 billion investment, underwritten by J.P. Morgan, will strengthen its cash position and support global growth and commercialization of its quantum computing, networking, and sensing technologies.
PRESS RELEASE — IonQ (NYSE: IONQ), a leading quantum company, today announced the pricing of a $2.0 billion equity offering consisting of 16,500,000 shares of IonQ’s common stock, each at $93 per share, and pre-funded warrants to purchase 5,005,400 shares of IonQ’s common stock, each at $93 per pre-funded warrant, each representing a premium of 20% to IonQ’s closing stock price on October 9, 2025, as well as seven-year warrants to purchase 43,010,800 additional shares of IonQ’s common stock, which warrants will be exercisable at an exercise price of $155 per share, which exercise price represents a premium of 100% to IonQ’s closing stock price on October 9, 2025. The securities offered will be purchased from the underwriter by an entity managed by Heights Capital Management, Inc. (the “investor”).
“This investment provides an opportunity for the IonQ team to continue to grow and expand our ecosystem. IonQ is one of the only quantum companies in the world capable of delivering advanced computing, networking, and sensing solutions across every theatre – on the ground, in the air, and in space,” said Niccolo de Masi, Chairman and CEO of IonQ. “With our accelerated technology roadmap, world-renowned talent, and robust net cash position, we have strengthened our unique position. We believe this is the largest common-stock single-institutional investment in the history of the quantum industry. This $2 billion cash investment will facilitate our global growth and accelerate our quantum commercialization worldwide.”
J.P. Morgan acted as the sole underwriter in the transaction. Paul, Weiss, Rifkind, Wharton & Garrison LLP served as legal counsel to IonQ. Simpson Thacher & Bartlett LLP acted as legal counsel to J.P. Morgan. Skadden, Arps, Slate, Meagher & Flom LLP acted as legal counsel to the investor.
A shelf registration statement (including a prospectus) relating to these securities has been filed with the Securities and Exchange Commission (“SEC”) and is effective. Before investing, interested parties should read the prospectus supplement and accompanying prospectus and other documents filed with the SEC for information about IonQ and this offering. You may get these documents for free by visiting EDGAR on the SEC website at sec.gov. Alternatively, a copy may be obtained from J.P. Morgan Securities LLC, 383 Madison Avenue, New York, NY 10179, or by email at [email protected] or [email protected].
This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.
